A Quantitative Enzyme-Linked Immunosorbent Assay for Shiga Toxin 2a Requiring Only Commercially Available Reagents
DOI:
https://doi.org/10.17140/aftnsoj-3-139Keywords:
Shiga toxin-producing E. coli, E. coli O157:H7, ELISA, Shiga toxin 2Abstract
Aim: This study develops a quantitative ELISA for measuring Shiga toxin 2 (Stx2) produced by Shiga toxin (Stx)-producing Escherichia coli (STEC), including foodborne pathogen E. coliO157:H7 by all commercially available reagents.
Background: Most foodborne outbreak strains of STEC produce Stx2a, Stx2c or both, which are more frequently associated with human clinical cases, leading to severe gastrointestinal dis-eases or even death. However, no simple and cheap assays or kits are available for quantitative detection of Stx2a and Stx2c. Therefore, an easy and affordable quantitative method for Stx2 is needed for its pathogenesis study.
Results: We successfully developed a sensitive and specific receptor-based ELISA by using all commercial available agents. Hydroxyl acyl ceramide trihexoside, an analogue of Stx2 receptor globotriaosylceramide (Gb3), was used for antigen capture, and several critical steps were identified that must be adhered to ensure repeatability. No cross reactivity was observed with Stx1, and linear curves could be constructed using either purified Stx2a or a bacterial lysate from an Stx2a-producing E. coli O157:H7 strain. We applied this method to quantify Stx2 pro-duction by a collection of E. coli O157:H7 strains, indicating it can be extended to qualitatively evaluate Stx2c, and providing evidence that toxin production does not necessarily correlate with strain phylogeny.
Conclusion: Our R-ELISA provides a reliable way to quantify Stx2a using commercially avail-able components, and it can also be used for detecting Stx2c. This cost-effective ELISA can be easily performed, suggesting it will be a useful tool for studying pathogenesis of STEC.
References
Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005; 365: 1073-1086. doi: 10.1016/S0140-6736(05)71144-2
Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008; 23: 1749-1760. doi: 10.1007/ s00467-008-0935-6 Page 11 ADVANCES IN FOOD TECHNOLOGY AND NUTRITIONAL SCIENCES Open Journal
Heiman KE, Mody RK, Johnson SD, Griffin PM, Gould LH. Escherichia coli O157 outbreaks in the United States, 2003-2012. Emerg Infect Diseases. 2015; 21: 1293-1301. doi: 10.3201/eid2108.141364
Locking ME, Pollock KGJ, Allison LJ, Rae, L, Hanson MF, Cowden JM. Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis. 2011; 17: 524- 527. doi: 10.3201/eid1703.100167
Kim J, Nietfeldt J, Benson AK. Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle. Proc Natl Acad Sci U S A. 1999; 96: 13288-13293. doi: 10.1073/pnas.96.23.13288
Manning SD, Motiwala AS, Springman AC, et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A. 2008; 105: 4868-4873. doi: 10.1073/pnas.0710834105
Hartzell A, Chen C, Lewis C, Liu K, Reynolds S, Dudley EG. Escherichia coli O157:H7 of genotype lineage-specific polymorphism assay 211111 and clade 8 are common clinical isolates within Pennsylvania. Foodborne Pathog Dis. 2011; 8: 763-768. doi: 10.1089/fpd.2010.0762
Mellor GE, Besser TE, Davis MA, et al. Multilocus genotype analysis of Escherichia coli O157 Isolates from Australia and the United States provides evidence of geographic divergence. Appl Environ Microbiol. 2013; 79: 5050-5058. doi: 10.1128/ AEM.01525-13
Iyoda S, Manning SD, Seto K, et al. Phylogenetic clades 6 and 8 of enterohemorrhagic O157:H7 with particular Stx subtypes are more frequently found in isolates from HUS patients than from asymptomatic carrier. Open Forum Infec Dis. 2014; 6: 1-8
Amigo N, Mercado E, Bentancor A, et al. Clade 8 and clade 6 strains of Escherichia coli O157:H7 from cattle in Argentina have hypervirulent-like phenotypes. PLoS One. 2015; 10: e0127710. doi: 10.1371/journal.pone.0127710
Karch FH, Heesemann J, Laufs R, Brien ADO, Tacket C, Levine MM. A Plasmid of enterohemorrhagic Escherichia coli O157 : H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun. 1987; 55: 455- 461
Donnenberg MS, Tzipori S, McKee ML, O’Brien AD, Alroy J, Kaper JB. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest. 1993; 92: 1418-1424. doi: 10.1172/ JCI116718
Mauro SA, Koudelka GB. Shiga toxin: Expression, distribution, and its role in the environment. Toxins. 2011; 3: 608-625. doi: 10.3390/toxins3060608
Fraser ME, Fujinaga M, Cherney MM, et al. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem. 2004; 279: 27511-27517. doi: 10.1074/jbc.M401939200
Waddell T, Cohen A, Lingwood CA. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A. 1990; 87: 7898-7901. doi: 10.1073/pnas.87.20.7898
Schüller S. Shiga toxin interaction with human intestinal epithelium. Toxins. 2011; 3: 626-639. doi: 10.3390/toxins3060626
Tesh VL, O’Brien AD. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol. 1991; 5: 1817- 1822. doi: 10.1111/j.1365-2958.1991.tb00805.x
Head SC, Karmalisg MA, Lingwood CA. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. J Biol Chem. 1991; 6: 3617-3621
Rutjes NWP, Binnington BA, Smith CR, Maloney MD, Lingwood CA. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int. 2002; 62: 832-845. doi: 10.1046/j.1523-1755.2002.00502.x
Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol. 2003: 18: 92-96. doi: 10.1007/s00467-002-1035-7
Tesh VL, Burris JA, Owens JW, et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun. 1993; 61: 3392-3402
Kawano K, Okada M, Haga T, Maeda K, Goto Y. Relationship between pathogenicity for humans and Stx genotype in Shiga toxin-producing Escherichia coli serotype O157. Eur J Clin Microbiol Infect Dis. 2008; 27: 227-232. doi: 10.1007/s10096- 007-0420-3
Scheutz F, Teel LD, Beutin L, et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol. 2012; 50: 2951- 2963. doi: 10.1128/JCM.00860-12
Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: Frequency and association with clinical symptoms. J Infect Dis. 2002; 185: 74-84. doi: 10.1086/338115
Persson S, Olsen KEP, Ethelberg S, Scheutz F. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol. 2007; 45: 2020-2024. doi: 10.1128/JCM.02591-06
Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. Associations between virulence factors of ADVANCES IN FOOD TECHNOLOGY AND NUTRITIONAL SCIENCES Open Journal Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol. 1999; 37: 497-503
Ethelberg S, Olsen KEP, Scheutz F, et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis. 2004; 10: 842-847. doi: 10.3201/eid1005.030576
Zhang Y, Laing C, Zhang Z, et al. Lineage and host source are both correlated with levels of Shiga toxin 2 production by Escherichia coli O157:H7 strains. Appl Environ Microbiol. 2010: 76: 474-482. doi: 10.1128/AEM.01288-09
Abu-Ali GS, Ouellette LM, Henderson ST, et al. Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One. 2010; 5: 1-10. doi: 10.1371/journal. pone.0010167
Neupane M, Abu-Ali GS, Mitra A, Lacher DW, Manning SD, Riordan JT. Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb Pathog. 2011; 51: 466-470. doi: 10.1016/j.micpath.2011.07.009
Yin S, Rusconi B, Sanjar F, et al. Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phages. BMC Genomics. 2015; 16: 733-746. doi: 10.1186/s12864-015-1934-1
Ball HJ, Finlay D, Zafar A, Wilson T. The detection of verocytotoxins in bacterial cultures from human diarrhoeal samples with monoclonal antibody-based ELISAs. J Med Microbiol. 1996; 44: 273-276. doi: 10.1099/00222615-44-4-273
He X, Patfield S, Hnasko R, Rasooly R, Mandrell RE. A polyclonal antibody based immunoassay detects seven subtypes of Shiga toxin 2 produced by Escherichia coli in human and environmental samples. PLoS One. 2013; 8: e76368. doi: 10.1371/ journal.pone.0076368
Ashkenazi S, Cleary TG. Rapid method to detect Shiga toxin and Shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. J Clin Microbiol. 1989; 27: 1145- 1150
Acheson DW, Jacewicz M, Kane AV, Donohue-Rolfe A, Adv Food Technol Nutr Sci Open J Keusch GT. One step high yield affinity purification of Shigalike toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb Pathog. 1993; 14: 57-66. doi: 10.1006/mpat.1993.1006
Basta M, Karmali M, Lingwood C. Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin. J Clin Microbiol. 1989; 27: 1617-1622
Strauch E, Schaudinn C, Beutin L. First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157. Infect Immun. 2004; 72: 7030-7039. doi: 10.1128/ IAI.72.12.7030-7039.2004
Togashi K, Sasaki S, Sato W. A globotetraosylceramide (Gb4) receptor-based ELISA for quantitative detection of Shiga toxin 2e. J Vet Med Sci. 2015; 77: 973-976. doi: 10.1292/ jvms.14-0071
Gallegos KM, Conrady DG, Karve SS, Gunasekera TS, Herr AB, Weiss AA. Shiga toxin binding to glycolipids and glycans. PLoS One. 2012; 7: e30368. doi: 10.1371/journal.pone.0030368
Serra-Moreno R, Jofre J, Muniesa M. The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol. 2008; 190: 4722-4735. doi: 10.1128/JB.00069-08
Hayes PS, Blom K, Feng P, Lewis J, Strockbine NA, Swaminathan B. Isolation and characterization of a beta-D-glucuronidase-producing strain of Escherichia coli serotype O157:H7 in the United States. J Clin Microbiol. 1995; 33: 3347-3348
Liu K, Knabel SJ, Dudley EG. rhs genes are potential markers for multilocus sequence typing of Escherichia coli O157:H7 strains. Appl Environ Microbiol. 2009; 75: 5853-5862. doi: 10.1128/AEM.00859-09
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Advances in Food Technology and Nutrition Sciences (AFTNS) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.